Study of immunotherapy of murine myeloma by an IL-21-based tumor vaccine in BALB/C mice

Cancer Biology and Therapy

Volumn 6, Issue 12, 2007, Pages 1871-1879

  Dou, Jun ^a   Chu, Lili ^a,b   Zhao, Fengshu ^a   Tang, Quan ^a   Zhang, Aifeng ^a   Zhang, Lanfang ^b   Wang, Yongfang ^a   Li, Yating ^a   Cao, Minggang ^a   Gu, Ning ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b CHILDREN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Anti tumor efficacy; Immune adjunctive; Murine interleukin 21; Murine myeloma cells; Plasmid DNA; Tumor vaccine; Tumor bearing mice

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 21; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PLASMID DNA; TUMOR VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; BAGG ALBINO MOUSE; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG EFFICACY; DRUG MECHANISM; IMMUNE RESPONSE; MOUSE; MYELOMA; NATURAL KILLER CELL; NONHUMAN; TUMOR GROWTH; UPREGULATION;

EID: 42549159100     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.6.12.4960     Document Type: Article

References (32)